Concepedia

Publication | Closed Access

Phase I trial of weekly scheduling and pharmacokinetics of titanocene dichloride in patients with advanced cancer.

DOI

105

Citations

13

References

1998

Year

Constantina Christodoulou, D. Ferry, D. Fyfe, Anna-Mary Young, J Doran, T. M. T. Sheehan, Aristides G. Eliopoulos, K Hale, Joachim Baumgart, G Sass,
Journal of Clinical Oncology

Abstract

The MTD of TD given on a weekly schedule is 140 mg/m2, with cumulative, but reversible creatinine and bilirubin elevation being the DLTs.

References

YearCitations

Page 1